Aganepag is a potent prostanoid EP2 receptor agonist for research use, applied in preclinical studies of EP2 signaling, wound healing, scar reduction, and dermatological research. It has a low EC50 and defined chemical properties suitable for biochemical and cell-based assays.
- Potent EP2 receptor agonist (EC50 0.19 nM).
- High purity (~99.7%).
- Molecular weight 429.57.
- Chemical formula C24H31NO4S.
- Suitable for in vitro and preclinical research applications.
- Available in small research pack sizes such as 10 MG.